Thiol-disulfide interchange in the tocinoic acid/glutathione system during freezing and drying.
Thiol-disulfide interchange ("disulfide scrambling") is a common mechanism of covalent aggregation for protein drugs. Using tocinoic acid (cyclo-S-Cys-Tyr-Ile-Gln-Asn-Cys-(S); TA(ox)) and glutathione (γGlu-Cys-Gly; GSH), our previous work demonstrated that thiol/disulfide interchange is affected by lyophilization in a manner consistent with irreversible and regioselective loss of TA(ox) (Zhang et al., 2009, J Pharm Sci 98/9: 3312-3318). Here, we explore the contributions of stages of the lyophilization cycle to perturbations in thiol/disulfide interchange in the TA/GSH system. TA(ox) and GSH were co-lyophilized from phosphate buffer in the presence or absence of various excipients, then analyzed for TA(ox) and mixed disulfide products by reverse phase high performance liquid chromatography (rp-HPLC). Perturbations were found to occur primarily during freezing, before significant amounts of ice were removed by sublimation. Addition of a lyoprotectant (sucrose), a cryoprotectant (Tween-20) and flash-freezing influenced the product distribution only while ice was still present. Decreasing the redox potential by the addition of oxidized glutathione (GSSG) affected the product distribution differently in lyophilized samples and solution controls, but in neither case led to increased conservation of TA(ox).
Thing
Mette
M
Department of Pharmaceutical Chemistry, The University of Kansas, Lawrence, Kansas, USA.
Zhang
Jun
J
Laurence
Jennifer
J
Topp
Elizabeth M
EM
D002851:Chromatography, High Pressure Liquid / Q000379:methods; D003890:Desiccation; D004151:Dipeptides / Q000737:chemistry; D004220:Disulfides / Q000737:chemistry / Q000378:metabolism*; D005612:Freeze Drying; D005615:Freezing; D005978:Glutathione / Q000032:analysis / Q000737:chemistry / Q000378:metabolism*; D019803:Glutathione Disulfide / Q000378:metabolism; D010121:Oxytocin / Q000031:analogs & derivatives* / Q000032:analysis / Q000378:metabolism; D011506:Proteins / Q000494:pharmacology; D013438:Sulfhydryl Compounds / Q000378:metabolism*
D004151:Dipeptides; D004220:Disulfides; D011506:Proteins; D013438:Sulfhydryl Compounds; C100032:tocinoic acid; C028505:cysteinylglycine; D010121:Oxytocin; D005978:Glutathione; D019803:Glutathione Disulfide
Int J Pharm. 2005 Jan 31;289(1-2):1-30
15652195
Adv Protein Chem. 1978;32:283-326
362871
Methods Enzymol. 1995;251:8-28
7651233
Anal Chem. 1993 Nov 1;65(21):3061-6
8256869
J Pharm Sci. 2005 Jul;94(7):1427-44
15920775
J Pharm Sci. 2009 Sep;98(9):3312-8
18683877
AAPS PharmSci. 2003;5(2):E10
12866937
J Chromatogr A. 2000 Sep 8;891(2):235-42
11043783
J Pharm Sci. 2004 Mar;93(3):684-96
14762907
AAPS PharmSciTech. 2005 Sep 30;6(2):E150-7
16353972
J Biol Chem. 1992 Aug 15;267(23):16069-75
1644794
Cryobiology. 2005 Dec;51(3):262-80
16140290